[go: up one dir, main page]

AU2002214978A1 - Beta-Thio-amino acids - Google Patents

Beta-Thio-amino acids

Info

Publication number
AU2002214978A1
AU2002214978A1 AU2002214978A AU2002214978A AU2002214978A1 AU 2002214978 A1 AU2002214978 A1 AU 2002214978A1 AU 2002214978 A AU2002214978 A AU 2002214978A AU 2002214978 A AU2002214978 A AU 2002214978A AU 2002214978 A1 AU2002214978 A1 AU 2002214978A1
Authority
AU
Australia
Prior art keywords
thio
beta
amino acids
acids
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002214978A
Other versions
AU2002214978B2 (en
Inventor
Boris Chizh
D. Enders
Gero Gaube
Matthias Gerlach
Michael Haurand
Claudia Putz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10045831A external-priority patent/DE10045831A1/en
Priority claimed from DE10049484A external-priority patent/DE10049484A1/en
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Priority claimed from PCT/EP2001/010488 external-priority patent/WO2002022568A1/en
Publication of AU2002214978A1 publication Critical patent/AU2002214978A1/en
Application granted granted Critical
Publication of AU2002214978B2 publication Critical patent/AU2002214978B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002214978A 2000-09-14 2001-09-11 Beta-Thio-amino acids Ceased AU2002214978B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10045831A DE10045831A1 (en) 2000-09-14 2000-09-14 Anticonvulsant, anxiolytic and especially analgesic medicaments, comprising new or known beta-thio-alpha-aminoacid compounds having strong affinity for gabapentin binding site
DE10045831.9 2000-09-14
DE10049484A DE10049484A1 (en) 2000-09-29 2000-09-29 Anticonvulsant, anxiolytic and especially analgesic medicaments, comprising new or known beta-thio-alpha-aminoacid compounds having strong affinity for gabapentin binding site
DE10049484.6 2000-09-29
PCT/EP2001/010488 WO2002022568A1 (en) 2000-09-14 2001-09-11 ss-THIO-AMINO ACIDS

Publications (2)

Publication Number Publication Date
AU2002214978A1 true AU2002214978A1 (en) 2002-06-13
AU2002214978B2 AU2002214978B2 (en) 2006-08-31

Family

ID=26007074

Family Applications (2)

Application Number Title Priority Date Filing Date
AU1497802A Pending AU1497802A (en) 2000-09-14 2001-09-11 Ss-thio-amino acids
AU2002214978A Ceased AU2002214978B2 (en) 2000-09-14 2001-09-11 Beta-Thio-amino acids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU1497802A Pending AU1497802A (en) 2000-09-14 2001-09-11 Ss-thio-amino acids

Country Status (16)

Country Link
US (1) US6846843B2 (en)
EP (1) EP1317426B1 (en)
JP (1) JP2004509101A (en)
AR (1) AR030662A1 (en)
AT (1) ATE309983T1 (en)
AU (2) AU1497802A (en)
CA (1) CA2421990C (en)
DE (1) DE50108104D1 (en)
DK (1) DK1317426T3 (en)
ES (1) ES2252310T3 (en)
HU (1) HUP0302912A3 (en)
MX (1) MXPA03002090A (en)
NZ (1) NZ525143A (en)
PE (1) PE20020426A1 (en)
PL (1) PL361424A1 (en)
WO (1) WO2002022568A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NI200300043A (en) 2002-03-28 2003-11-05 Warner Lambert Co AMINO ACIDS WITH AFFINITY FOR THE PROTEIN a2DELTA.
US7659305B2 (en) 2002-10-31 2010-02-09 Pfizer Inc. Therapeutic proline derivatives
CA2451267A1 (en) 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
EP2196201A3 (en) 2002-12-13 2010-12-08 Warner-Lambert Company LLC Combination of an alpha-2-delta ligand with a pdev inhibitor or a muscarinic antagonist to treat lower urinary tract symptoms
ATE449633T1 (en) 2003-09-12 2009-12-15 Pfizer COMBINATIONS OF ALPHA-2-DELTA LIGANDS AND SEROTONIN / NORADRENALINE REUPPOST INHIBITORS
CA2540247C (en) 2003-09-25 2011-01-25 Warner-Lambert Company Llc Prodrugs of amino acids with affinity for the .alpha.2.delta.-protein
US20080153888A1 (en) 2006-12-22 2008-06-26 Recordati Ireland Limited Alpha-2-delta ligand/nsaid therapeutic treatment of lower urinary tract disorders
TW200908957A (en) * 2007-06-15 2009-03-01 Xenoport Inc Use of prodrugs of GABA analogs, antispasticity agents, and prodrugs of GABAB receptor agonists for treating spasticity
US8785370B2 (en) 2007-10-05 2014-07-22 Keratin Complex Holdings, Inc. Reactive keratin protein formulations and methods of using for revitalizing hair
RU2010116344A (en) * 2007-10-05 2011-11-10 Петер КОППОЛА (US) METHOD FOR TREATMENT FOR HEALTHY HAIR AND PREPARATION OF TREATMENT KERATIN PROTEIN SOLUTION
KR101751553B1 (en) 2009-06-30 2017-06-27 바스프 에스이 Aqueous alkaline cleaning compositions and methods of their use
RU2578718C2 (en) 2010-07-19 2016-03-27 Басф Се Aqueous alkaline cleaning compositions and methods for use thereof
WO2015064453A1 (en) * 2013-11-01 2015-05-07 株式会社糖鎖工学研究所 Method for producing d-form or l-form amino acid derivative having thiol group
WO2024022998A1 (en) * 2022-07-26 2024-02-01 Inke, S.A. Process for preparing daprodustat and cocrystals thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
NL144484B (en) 1967-07-26 1975-01-15 Merck & Co Inc PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTI-ANFLAMMATORY ACTION AND A PROCESS FOR THE PREPARATION OF THE ANTI-INFLAMMATORY ACTIVE ARALKYL MERCAPTOAMINO ACIDS.
DE2460891C2 (en) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-aminomethyl-1-cycloalkaneacetic acids and their esters, processes for their preparation and medicaments containing these compounds
HUT40447A (en) 1984-03-29 1986-12-28 Sandoz Ag Process for preparing substituted alpha-amino acids and pharmaceutical compositions containing such compounds
DE3727897A1 (en) 1987-08-21 1989-03-02 Degussa METHOD FOR PRODUCING N-ACYLATED MERCAPTO (ALPHA) AMINO ACIDS
DE3821540A1 (en) 1988-06-25 1989-12-28 Boehringer Mannheim Gmbh NEW SULFONAMIDES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAL PRODUCTS CONTAINING SULFONAMIDES
JPH0659399A (en) * 1992-08-10 1994-03-04 Konica Corp Color development processing tablet for silver halide photographic color sensitive material
US5401839A (en) * 1993-03-23 1995-03-28 Lever Brothers Company, Division Of Conopco, Inc. Process of preparing N-substituted aldonamides having improved color and color stability
US6620848B2 (en) * 1997-01-13 2003-09-16 Smithkline Beecham Corporation Nitric oxide synthase inhibitors
GB9808667D0 (en) * 1998-04-23 1998-06-24 Merck Sharp & Dohme Therapeutic compounds
CA2339273C (en) * 1998-09-14 2005-10-18 Warner-Lambert Company Branched alkyl pyrrolidine-3-carboxylic acids
WO2000031020A1 (en) * 1998-11-25 2000-06-02 Warner-Lambert Company Improved gamma amino butyric acid analogs
US6225311B1 (en) * 1999-01-27 2001-05-01 American Cyanamid Company Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
CA2362831C (en) * 1999-02-18 2008-10-07 F. Hoffmann-La Roche Ag Thioamide derivatives
WO2000074705A1 (en) * 1999-06-08 2000-12-14 Peter Prehm Rheumatic autoimmune disease antigen
US6642398B2 (en) * 1999-06-10 2003-11-04 Warner-Lambert Company Mono-and disubstituted 3-propyl gamma-aminobutyric acids
AU7904500A (en) * 1999-09-16 2001-04-17 Warner-Lambert Company Method for the screening of alpha2delta-1 subunit binding ligands

Similar Documents

Publication Publication Date Title
AU6419701A (en) Electropancreatography
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2002211620A1 (en) Autoanastomosis
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001220246A1 (en) Neckphone
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001296577A1 (en) Chlorophyllases
AU2001258349A1 (en) Bisacylguanidine
AU2001279754A1 (en) Indoloquinazolinones
AU2002211128A1 (en) Step-bike
AU2001290931A1 (en) Ski-snowboard
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2002214978A1 (en) Beta-Thio-amino acids
AU2001293852A1 (en) Sulfonylguanidine
AU2001258924A1 (en) Microsatellite-aflp
AU2002226346A1 (en) 2-aryl-5-trifluoromethylpyridines
AU2001281921A1 (en) Bdellosomes
AU2001246864A1 (en) Hypotensors
AU2001291876A1 (en) Triazolo-epothilones
AU2002214354A1 (en) Neck-phone
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001262711A1 (en) Cytoprotectors
AU2001260192A1 (en) Glycinamides